text:
CML Experts
Team of experts on CML who developed imatinib
Dr. Elisabeth Buchdunger
Dr. Brian Druker
Dr. John Goldman
Dr. Nora C. Heisterkamp
Dr. David Hungerford
Dr. Nicholas Lydon
Dr. Alex Matter
Dr. Felix Mitelman
Dr. Peter C. Nowell
Dr. Carlo Gambacorti-Passerini
Dr. Moshe Talpaz
Dr. Janet D. Rowley
Dr. Charles Sawyers
Dr. Jürg Zimmermann
Dr. Owen Witte
Experts involved in developing dasatinib
Dr. Jagabandhu Das
Experts involved in developing nilotinib
Other CML experts in America
Other CML experts in Canada
Dr. Sarit Assouline
Dr. Lambert Busque
Dr. Robert Delage
Dr. Connies Eaves
Dr. Josée Hébert
Dr. Pierre Laneuville
Dr. Isabelle Bence-Bruckler
Dr. Jeffrey H Lipton
Dr. Luigina Mollica
Other CML experts in US
Carolyn Blasdel, RN , FNP-BC, OCN
Rey Garcia, RN, BSN
Dr. Ravi Bhatia
Dr. Jorge E. Cortes
Dr. Arul Chinnaiyan
Dr. Michael Deininger
Dr. James D. Griffin
Dr. Frank Giles
Dr. Elias J. Jabbour
Dr. Hagop Kantarjian
Dr. Harry P. Erba
Dr. Richard A. Larson
Dr. Alison Loren
Dr. Michael Mauro
Dr. Stephen D. Nimer
Dr. Ruben A. Mesa
Dr. Susan M. O'Brien
Dr. Jerald P. Radich
Dr. Karen Seiter
Dr. Neil Shah
Dr. Richard Stone
Dr. Raoul Tibes
Dr. Bin Zhang
Other CML experts in South America
Dra Beatriz Moiraghi
Dr Carolina Pavlovsky
Other CML Experts in Europe
Dr. Jane Apperley
Dr. Michele Baccarani
Pr. Agnès Buzyn
Dr Aude Charbonnier
Dr. Gabriel Etienne
Dr. Marie-Joëlle Mozziconacci
Dr. François Guilhot
Dr. Eliane Gluckman
Dr. Andreas Hochhaus
Dr. Martin Müller
Dr. Stephen O'Brien
Dr Françoise Huguet
Stéphane Prost
Dr. Tessa L Holyoake
Dr. Hana Klamova
Dr. Jeroen J.W.M. Janssen
Dr. Franck-Emmanuel Nicolini
Dr. Delphine Rea
Dr. Johan Richter
Dr. Philippe Rousselot
Dr. Giuseppe Saglio
Dr. François-Xavier Mahon
Pr Gregor Verhoef
Other CML experts in Asia
Dr. Charles Chuah
Dr. Goh Yeow Tee
Dr. Pankaj Malhotra
Dr. Hemant Malhotra
Dr. Kim Dong-Wook
Other CML experts in Africa
Dr. Anthony Oyekunle
Other CML experts in Australia
Dr. Susan Branford
Pr Tim Hughes
Dr. Anthony P Schwarer
Medical Concepts
Introduction to CML
Bone Marrow
Immune System
Natural killer cell - NK
T Cells
JAK2 Gene
Philadelphia chromosome
Precision medicine in chronic myeloid leukemia
Polymerase Chain Reaction
Dr. Kary Bank Mullis
Treatment response in CML
Molecular monitoring in CML
Stem Cells
Donor lymphocyte infusion (DLI)
Blood-Brain Barrier
Interferon regulatory factor 8 (IRF8)
Myeloproliferative disorders (MPD)
Introduction to CML
Essential Thrombocythemia (ET)
Myelofibrosis (MF)
Polycythemia Vera (PV)
Types of leukemia
Atypical chronic myeloid leukemia
Interferon Alpha
Gleevec (Imatinib)
Generic Gleevec (Imatinib)
Tasigna (Nilotinib)
Sprycel (Dasatinib)
Bosulif (Bosutinib)
Iclusig (Ponatinib)
Supect (Radotinib)
ABL001 (Asciminib)
Synribo (Omacetaxine )
Jakafi (Ruxolitinib)
Vidaza (Azacitidine)
Managing side effects
List of side effets
Bone Pain
Fluid Retention
Gastrointestinal system
Muscle cramping
Peripheral Neuropathy in CML
Peripheral arterial disease in CML
Pleural effusion
Pulmonary arterial hypertension
Thyroid dysfunction
Weight gain
CML and Nutrition
Complementary and Alternative Medicine
Art Therapy
Art Therapist
CMLer's portofolio
Music therapy
YouTube creation by CMLer's family
Relaxing Music for Stress Relief. Calm Music for Meditation, Sleep, Healing Therapy, Spa
Debussy – Relaxing music - Clair de lune et autres...
Therapeutic Music for Rest and Wellness Music for Sleep
Delicate music for the soul and LIFE, and birdsong soothes the nervous system.
Amélie Soundtrack ♥ Comptine d'Un Autre Été
Adagio for Strings (Samuel Barber)
Physical Activity
Patient Testimonials
Virginia Garner
Pat Elliott
Jan Geissler
Mel Mann
Tamera Simonson
Hans Loland
Abbi Evans
Brown Dudley
Erin Havel (Author)
Erin Zammett Ruddy
Rob Shick
Gary Gonzales
Ron Robbecke
Drew Johnston
Angela Tyrrell
Doug Jenson
Rich Jones
Kevin Williams
Jean McGlynn
Austin Granatowicz
Tom Cleaver
Others testimonials
Some celebrities
Alexa Score
Laura Boyd
Dr. Richard Rockefeller
Tim Holcomb
Doris Muramatsu
Ryan O'Neal
Charlie Schlatter
Kelvin Alston
Kareem Abdul-Jabar
Carlos Carrasco
Jason Blake
Brian Boyle
Roman Reigns
Rick Upchurch
Bud Romine - the first patient
Kayla Naton (Pregnancy)
Suzan Mc Namara and the petition
Access CML Drugs
Trey's CML Leukemia Blog
Living with CML
CMKID's blog – Dislodging the bullet
CML Recovery - Stopping KTI
Hans's Blog
Elizabeth's Blog - my leukemia journey
Elizabeth's Blog - Heart of the rose
Ian's Blog
Joe's Blog
Jon's Blog
Josh's Blog
Mannan's Blog
Justin Ozuna's Blog
Lindsey's Blog
Matt's Blog
Matthew's Blog
Michelle's Blog
Michelle D's Blog
Nayree's Blog
Rob's Blog
News on CML (Chronic myeloid leukemia)
English- Archives 2017-2016
English - Archives 2015-2001
French (Français)
Spanish (Español)
Various topics
You've just been diagnosed
Food and Drug Interactions
CML causes
Non-adherence of CML patients
Pronostic, life expectancy, quality of life, ..... in chronic myeloid leukemia
Vaccination of CMLers
History of CML
Cure possible for CML?
Hematopoietic stem cell transplantation using single UM171-expanded cord blood
Inhibitory effect of c-Myc on p53-induced apoptosis in leukemia cells
Inhibition of the protein Ezh2 can cure CML?
Combination of ruxolitinib with tyrosine kinase inhibitor
Combinaison of hydroxychloroquine with tyrosine kinase inhibitor
Combination of pioglitazone with tyrosine kinase inhibitor
Combination of miristen with tyrosine kinase inhibitor
Combination of Inecalcitol with tyrosine kinase inhibitor
Combination of dasatinib plus Nivolumab
Combination of Pembrolizumab with tyrosine kinase inhibitor
Combination of interferon with tyrosine kinase inhibitor
Combination of Venetoclax with tyrosine kinase inhibitor
PROTAC-mediated Targeted Protein Degradation
Inhibition of STAT5 in conjunction with standard TKI therapy
CML vaccine
Can immunotherapy cure leukemia?
Could fasting cure chronic myeloid leukemia
Chimeric Antigen Receptor T-Cell Therapy
Can genetic sequencing help to cure leukemia?
Natural Medicine
Possible cure for CML in Fish Oil
Betel leaf may help fight CML
Feverfew extract (parthenolide)
Can dandelions kill cancer?
Can curcumin cure leukemia?
Can the new drug CX-5461 cure leukemia?
CRISPR-Cas9 gene-editing technique
Presence of bcr abl fusion transcripts in healthy individua
Math could help cure leukemia
Treatment free remission (TFR)
The French trial called STIM (Stop Imatinib)
De-escalation of treatment
Tyrosine Kinase Inhibitor Withdrawal Syndrome in CML Patients
CML and pregnancy
Children with CML
Elderly patients with CML
Bone marrow transplant
CML Blast Crisis treatment
Stem cells from umbilical cord blood
Mutation T315I
Sensitive detection of BCR-ABL1 mutations
Living with CML and diabetes
Sports with CML
CML Awareness Day
The movie "Dying to Survive"
Congresses, conferences, meetings ASH, ASCO, EHA ...
ASCO - American Society of Clinical Oncology
ASCO 2019 - Chicago
ASCO 2018 - Chicago
ASCO 2017 - Chicago
ASCO 2016 - Chicago
ASCO 2015 - Chicago
ASCO 2014 - Chicago
ASCO 2013 - Chicago
ASCO 2012 - Chicago
ASCO 2011 - Chicago
ASCO 2010 - Chicago
ASH - American Society of Hematology
ASH 2019- Orlando
ASH 2018 - San Diego
ASH 2017 - Atlanta
ASH 2016 - San Diego
ASH 2015 - Orlando
ASH 2014 - San Francisco
ASH 2013 - New Orleans
ASH 2012 - Atlanta
ASH 2011 - San Diego
ASH 2010 - Orlando
ASH 2009 - New Orleans
BTG - Bridging the Gap
BTG 2011 - Singapore (Singapore)
CML & MPDs - UK National Meetings
CML Horizons
CML Horizon 2019 - Lisbon - Portugal
CML Horizon 2018 -Warsaw (Pologna)
CML Horizon 2017- Frankfurt (Germany)
CML Horizon 2016 - Ljubljana (Slovenia)
CML Horizons 2015 - (Barcelona, Spain)
CML Horizons 2014 - ( Belgrade, Serbia)
CML Horizons 2013 - (Prague - Czech Republic)
CML Horizons 2012 - (Munich, Germany)
CML Horizons 2011 - (Amsterdam - The Netherlands)
EHA - European Hematology Association
EHA 2019 - Amsterdam (Netherlands)
EHA 2018 - Stockholm(Sweden)
EHA 2017 - Madrid (Spain)
EHA 2015 - Vienne (Austria)
EHA 2014 - Milan (Italy)
EHA 2013 - Stockholm (Sweden)
EHA 2012 - Amsterdam (The Netherlands)
EHA 2011 - London (England)
EHA 2010 - Cascais (Portugal)
EHA 2009 - Berlin (Germany)
EHA 2008 - Copenhague (Danemark)
ESH - European School of Haematology
ESH 2020 - Mandelieu-La Napoule, -France
ESH 2019 - Bordeaux - France
ESH 2016 - Houston - USA
ESH 2015 - Estoril - Portugal
ESH 2014 - Philadelphia
Educational videos
Educational videos (in English)
Educación de vídeos en español (in Spanish)
Vidéos pédagogiques en français (in French)
Educational events
CML Glossaries
Professionnel help and literature
International publications
Publications from Africa
Publications from America
Publications from Australia
Publications from Asia
Publications from Europe
Specialist Journals in Hematology/Oncology
Patient Rights
Moral Support
Where to get help and support
Family support
I Had Cancer: You are not alone
I'm A Doctor With Chronic Illness. Here Are 12 Things I Wish People Knew
23 Nice Things You Can Do for Someone With Cancer
The march toward healing
Be happy
Dances at the Cancer Research Centre
The spoon theory
Magnificent - Beauty of nature
New technological advances
Links to other sites, forums and Facebook
Sites ( English and other languages)
CML on Facebook
CML on Twitter
Audio Podcast
Awards & Recognition
Leukemia Foundations
American Cancer Society
Hospital Foundations
SPECIAL Donation
About us
Contact us
Chronic Myeloid Leukemia
on Chronic Myeloid Leukemia (CML)
(Archives 2015-2017)
e our
Omitting cytogenetic assessment from routine treatment response monitoring in CML is safe
December 29, 2017,
European Journal of Haematology
MolecularMD Gets FDA Authorization for Companion Dx to Novartis CML Drug
December 27, 2017,
Nilotinib Label for CML Updated by FDA With Discontinuation Provision
December 26, 2017,
Targeted Oncology
Managing TKI Therapy in CML
December 22, 2017,
Targeted Oncology
The Deciding Factors for CML Treatment
December 22, 2018,
Targeted Oncology
MolecularMD obtains FDA Authorization for the MRDx® BCR-ABL Test as a Companion Diagnostic for Treatment-Free Remission in Ph+ CML-CP Patients Treated with Tasigna
December 22, 2017,
Markets Insider
Radioactive Iodine Increases Risk of AML, CML in Patients With Thyroid Cancer
December 19, 2017,
Cancer therapy advisor
FDA Approves Bosutinib for Newly-Diagnosed Ph+ CML
December 19, 2017,
Jorge Cortes, MD, shares data presented at ASH 2017 regarding bosutinib in CML treatment
December 18, 2017,
What is treatment free remission in chronic myeloid leukemia?
December 18, 2017,
Auto-Commentary on: "Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells"
December 17, 2017,
Molecular & Cellular Oncology
Peripheral Artery Occlusive Disease Among Patients With Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors: A Cross-Sectional Case-Control Study
December 15, 2017,
Older adults underrepresented in clinical trials for blood cancers
December 15, 2017,
Arterial Thrombotic Events Associated With First-line Nilotinib for CML in Older Adults
December 11, 2017,
Oncology Nurse Advisor
Nilotinib Dose, Frequency Reduction Maintains Efficacy in Chronic Myeloid Leukemia
December 10, 2017,
Cancer Therapy Advisor
Sprycel (dasatinib) Added to Standard Chemotherapy Demonstrates Three-Year Survival Benefit in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
December 9, 2017,
Business Wire
Treatment-free remission in CML: who, how, and why?
December 8, 2017,
Altered intracellular signaling by imatinib increases the anti‐cancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia cells
December 7, 2017,
Bio-Rad Releases First CE-IVD Digital PCR Test for Monitoring Chronic Myeloid Leukemia Response to Therapy
December 7, 2017,
Select Science
C1206, a novel curcumin derivative, potently inhibits Hsp90 and human chronic myeloid leukemia cells in vitro
December 7, 2017,
More Communication, Support Needed to Manage Symptom Burden in CML
December 6, 2017,
Oncology Nurse Advisor
Systematic Review Finds Elevated Reporting for Thromboembolic Events With JAK Inhibitors
December 05, 2017,
Inotuzumab Ozogamicin Plus Bosutinib May Be Safe, Effective for Relapsed/Refractory ALL and CML
November 30, 2017,
Cancer Therapy Advisor
Imatinib Effective as Front-line Therapy for Pediatric Chronic Myeloid Leukemia
November 30, 2017,
Cancer Therapy Advisor
I'm A Doctor With Chronic Illness. Here Are 12 Things I Wish People Knew
November 28, 2017,
Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemia
November 28, 2017,
Do Additional Chromosomal Abnormalities Noted at CML Diagnosis Affect Response and Survival?
November 16, 2017,
Cancer Therapy Advisor
Immature CML cells implement a BMP autocrine loop to escape TKI treatment
November 14, 2017,
Journal Blood
FDA Approves Dasatinib for Pediatric Ph+ Chronic Phase CML
November 10, 2017,
Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors
November 9, 2017,
American Journal of Hematology
Prevalence and associated factors of medication non-adherence in hematological-oncological patients in their home situation
November 9, 2017,
Brian Boyle scores emotional first goal since cancer diagnosis (Video)
November 9, 2017,
NBC sports
Treatment-free remission in chronic myeloid leukaemia
November 2, 2017,
Bosutinib May Be Superior to Imatinib for Newly Diagnosed CML
November 1, 2017,
Cancer Therapy Advisor
Vitamin C Treatment Restores TET2 Deficiency and Confers Sensitivity to PARP Inhibition
October 27, 2017,
The hematologist
Bosutinib Safe, Effective in Second and Third Line Among Patients With CML
October 27, 2017.
Cancer Therapy Advisor
Life after ponatinib failure: outcomes of chronic and accelerated phase CML patients who discontinued ponatinib in the salvage setting
October 2017,
Gaps Found in Monitoring of Response to TKI Therapy in CML
October 4, 2017,
Cancer Network
Celyad reports a first complete response in a relapsed refractory AML patient in the THINK trial
October 3, 2017,
What's on the Horizon for Chronic Myeloid Leukemia?
September 27, 2017,
Existing drugs may be able to improve therapy for chronic myeloid leukemia, mice study shows
September 26, 2017,
News Medical
Novartis and The Max Foundation transform pioneering cancer access program for people in lower-income countries
September 23, 2017,
Science Business
A network of hope and strength: Living with CML
September 23, 2017,
The Daily Star
Leukemia Patients Celebrate 10th World CML Day
September 22, 2017,
This Day
Phase III clinical trial (RERISE study) results of Efficacy and safety of radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemia
September 22, 2017,
Trial Compares Bosutinib and Imatinib for First-Line CML Rx
September 21, 2017,
Clinical Oncology News
The Importance of Spotting Leukemia
September 20, 2017,
Jason Blake, who continued career after leukemia diagnosis, knows what Brian Boyle is facing
September 20, 2017,
The Hockey news
Imatinib a Double-Edged Sword for Patients With CML Who Become Pregnant
September 19, 2017,
Targeted antibiotic use may help cure chronic myeloid leukaemia
September 19, 2017,
Medical Xpress
Devils' Brian Boyle diagnosed with leukemia
September 19, 2017,
USA Today
The Transformation of CML Treatment and Care
September 15, 2017,
Patient Power
Bosutinib Distinguishes Itself as Potential Option for Newly-Diagnosed CML
September 15, 2017,
Targeted Oncology
US Clears First & Latest "Living Drug" for Leukemia Cancer Treatment
September 13, 2017,
Chronic Diseases
Hearing impairment helps him portray character
September 12, 2017,
Dr. Jorge Cortes Joins Dr. Andre Goy and Dr. Sagar Lonial as Co-Chair for the Landmark Physicians' Education Resource® International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma
September 06, 2017,
Business Wire
Using Patient Variables in CML to Guide Treatment
September 5, 2017,
Cancer Network
Experiences with cancer drive mother, daughter to complete triathlon
September 4, 2017,
Chicago Tribune
How I Treat In Brief: Atypical Chronic Myeloid Leukemia
September 1, 2017,
ASH Clinical News
Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results
September 1, 2017,
Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs
August 2017,
Natural Killer-Cell Counts Are Associated With Molecular Relapse-Free Survival After Imatinib Discontinuation In Chronic Myeloid Leukemia: The IMMUNOSTIM Study
August 2017,
The University of Glasgow is deeply saddened to learn of the passing of Professor Tessa Holyoake.
August 31, 2017,
University of Glasgow
Bosulif Granted Priority Review in CML
August 30, 2017,
FDA and EMA Accept Regulatory Submissions for Chronic Myeloid Leukemia Treatment
August 29, 2017, Rare Disease Report
U.S. FDA and European Medicines Agency Accept Regulatory Submissions for BOSULIF® (bosutinib) for the Treatment of Patients with Newly Diagnosed Ph+ Chronic Myeloid Leukemia
August 29, 2017,
Business wire
First-line imatinib at 10 years: CML patients achieve 'close to normal life expectancy'
August 29, 2017,
Last Days? Ryan O'Neal's Cancer May Have Returned, Friends Fear
Aug 25, 2017,
Radar Online
CT-721, a Potent Bcr-Abl Inhibitor, Exhibits Excellent In Vitro and In Vivo Efficacy in the Treatment of Chronic Myeloid Leukemia
August 23, 2017,
New Norton panther statue inspired by fallen football player
July 22, 2017,
Akron Beacon Journal
CML Patients Approach Normal Life Expectancy With Imatinib Treatment
July 21, 2017,
Cancer Network Hematology
FDA Grants Priority Review for New Leukemia Option
July 20, 2017,
Cancer Network
Patients misled: Indian drugs of uncertain quality are replacing FDA approved products
July 17, 2017,
New Approach to Leukemia Can Help Improve Successful Treatment
July 14, 2017,
Drug Discovery & Development
Genetically enhanced, cord-blood derived immune cells strike B-cell cancers
July 13, 2017,
Science Daily
DESTINY Study: De-Escalation of TKIs Is Safe for Patients With CML
July 13, 2017,
ASH Clinical News
FDA will review bid to extend label for Sprycel in chronic myeloid leukemia
July 12, 2017,
The Pharma Letter
Novel approach to leukemia therapy can safely improve treatment success, reduce side effects
July 12, 2017,
Sprycel Granted Priority Review for Pediatric CML
July 11, 2017,
Survival in Imatinib-Treated CML Independent of Response Time
July 10, 2017,
July 7, 2017, University of Glasgow
Evaluation of healthcare resource utilization and incremental economic burden of patients with chronic myeloid leukemia after disease progression to blast phase
July 6, 2017,
New Tool for Monitoring Molecular Response in Patients With Chronic Myeloid Leukemia
July 4, 2017,
Pfizer assembles findings from 13 cancers for American Society of Clinical Oncology
July 2, 2017,
Patient Daily
Dasatinib in Children: An Effective Alternative to Imatinib
June 29, 2017, Medscape
Onset of chronic myeloid leukemia with complex karyotype in a pregnant patient: case report and revision of literature
June 27, 2017,
Dove Medical Press
TKI Discontinuation for Patients With CML Could Save Billions
June 26, 2017,
Cancer Therapy Advisor
Kareem Abdul-Jabbar to keynote Dayton cancer symposium
June 26, 2017,
Dayton Daily News
Analyses of Treatment Outcome According to Age in Patients With Chronic Myeloid Leukemia Receiving Front-line Imatinib Therapy
June 24, 2017
, PublMed
Novartis data shows half of eligible Ph+ CML-CP patients remain in Treatment-free Remission nearly two years after stopping Tasigna®
June 23,2017,
Cancer Immunotherapy, Part 2: Efficacy, Safety, and Other Clinical Considerations
June 23,2017,
P&T Community
Frontline bosutinib 'an option' for newly diagnosed CP CML
June 22, 2017,
Relay for Life set June 23; Long chosen as Honorary Survivor
June 15, 2017,
State Gazette
Bristol-Myers Squibb says Phase II of Sprycel in pediatric chronic myeloid leukemia cases shows promise
June 10, 2017,
Patient Daily
Despite a rare cancer diagnosis and $12000-a-month medication, this couple is staying positive
June 9, 2017,
Duluth News Tribune
Bosutinib vs Imatinib for First-line Chronic Myeloid Leukemia Treatment
June 7, 2017,
Cancer Therapy Advisor
Study: Pharma Payments Correlate To Higher Prescription Rates
June 7, 2017,
Novartis drug Tasigna receives EU approval
June 6, 2017,
The FINANCIAL
Frontline Bostunib vs Imatinib in Chronic Myeloid Leukemia
June 6, 2017,
Cancer Network
Comparing Bosutinib Versus Imatinib in Newly Diagnosed CML
June 5, 2017, Targeted Oncology
Drug Helps Some Kids With Rare Type of Leukemia
June 5, 2017,
Repost: Celebrating Brian Druker (ASCO 2017) and Basic Research
June 5, 2017,
PLoS Blogs
Remembering Dr. Steve Collins
June 2, 2017,
Fred Hutch
Effects of Bosutinib Treatment on Renal Function in Patients With Philadelphia Chromosome-Positive Leukemias
June 2017,
Clinical Lymphoma, Myeloma and leukemia
Dominic Sanders: 5 Fast Facts You Need to Know
May 27, 2017,
H. Jean Khoury, 50, hematologist and pioneer in leukemia research, dies
May 26, 2017,
The Cancer Letter Publications
No silver bullet, but precision oncology can help doctors hit the target
May 23, 2017,
The Pharma Letter
A remembrance of H. Jean Khoury, MD
May 22, 2017,
Third-line TKI Increases Non-relapse Mortality After Allo-HSCT in CML
May 22, 2017,
Cancer Therapy Advisor
European Medicines Agency Validates Application for Bristol-Myers Squibb's Sprycel (dasatinib) in Children with Chronic Myelogenous Leukemia
May 19, 2017,
Could This Cancer Drug Benefit Patients with Severe Asthma?
May 19, 2017,
Pharmacy Times
Metabolism harnessed to reverse aggressiveness in leukemia
May 17, 2017,
Science Daily
Relay for Life Cart n' for a Cure a huge success
May 17, 2017,
Westmoreland News
Single cell focus reveals hidden cancer cells
May 16, 2017,
Medical Xpress
Airman beats leukemia into remission
May 13, 2017,
Air Force Link
Research: Blood cancer is most prevalent at 42
May 13, 2017,
The Standard
Cancer Experts, Patients, and Families Meet for Local Blood Cancer Conference
May 11, 2017,
PR Web
Return to glory days? Decatur tops Battle Ground, secures 4A state berth
May 11, 2017,
The News Tribune
Insurance Status Influences Chronic Myeloid Leukemia Survival Outcomes
May 9, 2017,
Cancer Network
Push continues for Nova Scotia to cover cancer medications taken at home
May 8, 2017,
Yarmouth county Vanguard
Novartis Has the Right Prescription for Profits
May 6, 2017,
BCR-ABL1 Transcript Type Predicts Outcomes After Imatinib in CML
May 4, 2017,
Cancer Therapy Advisor
Bone marrow transplant next step in Barbosa's battle with Leukemia
May 4, 2017,
Federal Way Mirror
Hinsdale police investigating mother's death as a homicide
She have CML since 2004
May 4, 2017
, WGNtv
Andover man lucky to be alive
May 2, 2017,
Wellsville Daily Reporter
Challenges in Molecular Monitoring for CML Treatment Response
May 2, 2017,
Cancer Network
CML patients in England win access to Incyte's Iclusig
May 2, 2017,
These leukemia patients weren't supposed to survive. Here's how they defied the odds.
April 29, 2017,
The Boston Globe
Two drugs from Massachusetts biotechs win FDA approval
April 28, 2017,
The Boston Globe
'Long-awaited' NICE nod for Iclusig in England
April 28, 2017,
The Pharma Letter
Characterizing Therapy-persistent Leukemic Stem Cells in CML
April 28, 2017,
Cancer Therapy Advisor
Scientists create leukaemia online tool to aid global search for cure
April 27 2017
, Medical Xpress
Novartis to pay $50M, lose some drug coverage in Korean bribery probe
April 27, 2017,
Rgenix hires ex-Novartis cancer staffer to trial GSK castoff
April 27, 2017,
Sellas Testing Galinpepimut-S Vaccine as Potential Therapy in Blood and Solid Cancers
April 27, 2017,
Immuno-Oncology News
he survivors: How an experimental treatment saved patients and changed medicine
April 25, 2017,
Lower dose may be feasible in older people
April 20, 2017,
Jaipur hospital launches project to help adults with cancer
April 20, 2017,
The Hindu,
First-line generic imatinib offers 'suboptimal efficacy'
April 19, 2017,
Atypical Chronic Myeloid Leukemia: Current Research and Treatment Strategies
April 17, 2017,
Cancer Therapy Advisor
Long-term treatment with bosutinib in a phase 1/2 study in Japanese chronic myeloid leukemia patients resistant/intolerant to prior tyrosine kinase inhibitor treatment
April 13, 2017,
Low body weight and body mass index may be associated with musculoskeletal pain following imatinib discontinuation in chronic myeloid leukemia
April 12, 2017,
Transplant for Chronic Myeloid Leukemia
April 10, 2017,
Targeted cancer treatment; what's causing all these outbreaks of strange diseases?
April 7, 2017,
Double trouble for CML - ABL001 and TKIs
April 5, 2017,
Science Translational Medicine
TKI rotation-induced persistent deep molecular response in multi-resistant blast crisis of Ph+ CML
April 4, 2017,
Relapse After CML Treatment Discontinuation
April 3, 2017,
Nilotinib Associated With Treatment-induced T2DM and Hyperlipidemia
March 31, 2017,
Cancer Therapy Advisor
Chronic Myeloid Leukemia NEJM publishes long-term results of Gleevec for 1106 patients worldwide
March 30, 2017,
The Cancer letter
Drastic cuts to NIH budget could translate to less innovation and fewer patents, study argues
March 30, 2017,
Los Angeles Times
TKIs Associated With Subclinical Pulmonary Hypertension in CML Patients
March 29, 2017,
Cancer Network
Corrigan will direct community band Sunday
March 29, 2017,
Sierre Star
Novel Therapeutic Target Shows Promise in Treatment-Resistant Leukemia
March 29, 2017,
Specialty Pharmacy Times
The chronic myeloid leukemia stem cell: stemming the tide of persistence
March 2017,
Journal Blood
CML treatment-free remission possible with nilotinib
March 29, 2017,
CML progression, outcome linked to smoking
March 29, 2017,
Is Gleevec a Wonder Drug for Cancer Treatment?
March 28, 2017,
Healthline News
How Big Data is Being Mobilized in the Fight Against Leukemia
March 27, 2017,
TKIs Linked to Pulmonary Hypertension in CML
March 27,2017,
Cancer Therapy Advisor
Comparative analysis of pulmonary hypertension in patients treated with imatinib, nilotinib and dasatinib
March 27, 2017,
New vitamin may help DNA repair, reverse ageing process: Study
March 25, 2017,
Business Standard
Immune Effector Recovery in Chronic Myeloid Leukemia and Treatment-Free Remission
April 24, 2017,
An Unexpected New Lung Function Has Been Found - They Make Blood
March 24, 2017,
Science Alert
TKI Use in Medicare Beneficiaries With Chronic Myeloid Leukemia
March 22, 2017,
Oncology Nursing News
Pediatric Chronic Myeloid Leukemia: Targeting Treatment
March 22, 2017,
Cancer Therapy Advisor
Parthenolide and DMAPT Induce Cell Death in Chronic Myeloid Leukemia Cells Via Generation of Reactive Oxygen Species
journal Blood
Scientists find possible Achilles heel of treatment-resistant cancers
March 20, 2017,
Chronic Myeloid Leukemia: How Big Data Is Helping In The Fight
March 19, 2017,
Imatinib efficacy for CML sustained over time
March 17, 2017,
Researchers find patients' annual financial burden under Medicare Part D is 'too much too soon'
March 17, 2017,
Medical Xpress
Improvement Needed in CML BCR-ABL1 Monitoring
March 16, 2017,
Cancer Therapy Advisor
Long-Term Response With Imatinib
March 14, 2017,
Oncology Nursing News
SDF1-3'A polymorphism is associated with increased risk of hematological malignancy: a meta-analysis
March 14, 2017,
Dove Medical Press
Full Transcript of Interview with Sellas on Galinpepimut-S Vaccine Being Tested for MPM
March 14, 2017,
Mesothelioma Research News
Factors influencing adherence in CML and ways to improvement: Results of a patient-driven survey of 2546 patients in 63 countries
March 13, 2017,
Journal of Cancer Research and Clinical Oncology
Strategies for Stopping TKIs in CML Growing Clearer
March 13, 2017,
Clinical Oncology News
Novartis' leukemia treatment embroiled in efficacy
March 13, 2017,
Treatment Choice in CML
March 13, 2017,
Kite Pharma: History In The Making?
March 13, 2017,
Seeking Alpha
The simple life: Nate
March 11, 2017,
Keyser Mineral Daily News Tribune
Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study
Journal Blood
New made-in-Singapore cancer drug could lower leukaemia mortality
March 10, 2017,
Channel NewsAsia
Made-in-Singapore drug for blood cancer to be tested
March 10, 2017,
The Straits Times
A New Chapter Begins With CML
March 9, 2017, Cure
Cancer Pill Gleevec Keeps Patients Alive and Well for a Decade
March 9, 2017,
NBC News
Chronic Myeloid Leukemia: Persistent Efficacy With Imatinib
March 9, 2017,
Cancer Therapy Advisor
International Chronic Myeloid Leukemia Foundation honors Dr. Jerald Radich
March 9, 2017,
Hutch News
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia
March 9, 2017,
Scientists Bet for Genetic 'Edition' of Cancer
March 8, 2017,
Prensa Latina
Miracle drug with Israeli roots saves Jewish hockey player hit with cancer
March 8, 2017,
Jewish Telegraphic Agency
A New Chapter Begins With CML
March 8, 2017,
Curing Chronic Myeloid Leukemia with Nilotinib or Dasatinib
March 7, 2017,
Journal Watch
Elbasvir/grazoprevir effective against HCV in those with blood disorders
March 6, 2017,
Prof Tessa Holyoake recognised for ground-breaking research into CML
March 6, 2017,
Glasgow, City of Science and Innovation
Leukemia drug works so well that some patients are now quitting it
March 6, 2017,
Pharmacy Today,
American Pharmacists Association
Altoona mother, newborn son beat the medical odds
March 3, 2017,
Pittsburgh Post-Gazette
Lin BioScience Licenses a Novel Anti-Cancer Therapy for Hematological Malignancies and Solid Tumors from Columbia University and Memorial Sloan Kettering Cancer Center - CDC7 inhibitor (LBS-007)
March 3, 2017,
Risk & reward: Stopping a cancer drug to see if you're cured
March 2, 2917,
Sellas gives positive clinical update
March 2, 2017,
BioPharma Dive
Risk & reward: Stopping a cancer drug to see if you're cured
March 2, 2017,
abc news
see the video
No pain, no gain: the forgotten patient-reported outcome?
March 2017,
The Lancet Haematology
CD86+ pDCs: A Marker for Treatment-free Remission in Chronic Myeloid Leukemia?
March 1, 2017,
Cancer Therapy Advisor
CML: Less Frequent Monitoring of BCR-ABL1 May Not Affect Outcomes
February 28, 2017,
Cancer Therapy Advisor
Trump used a rare disease survivor to take a shot at the FDA
February 28, 2017,
Man behind HelpSaveMatthew.com, Matthew Schreindorfer, dies after battle with cancer
February 27, 2017,
Montreal Gazette
Second-Generation TKIs Can Be Stopped in Many CML Patients
February 26, 2017,
Cancer Network
Georgetown Announces Phase II Clinical Trial of Nilotinib for Parkinson's Disease
February 26, 2017,
Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management
February 2017,
Clinical Lymphoma Myeloma& Leukemia
Smoking Worsens
Researchers identify factors associated with survival in patients with blast phase CML
February 24, 2017,
Prognosis for Patients With CML
February 24, 2017,
Cancer Network
Cobll1 is linked to drug resistance and blastic transformation in chronic myeloid leukemia
February 24, 2017,
CML: First-line Generic Imatinib May Be Inferior to Branded Imatinib
February 23, 2017,
Cancer Therapy Advisor
TKI rotation-induced persistent deep molecular response in multi-resistant blast crisis of Ph+ CML
February 18, 2017,
Cowboys, TeamConnor promoting marrow donor drive at The Star
February 16, 2017,
Fort Worth Star
Stopping second-generation TKIs in CML
February 16, 2017,
Journal Blood
Assays Break New Ground in Oncology
February 15, 2017,
Your Good Health: Soldier's exposure to cannons reverberates in ears for years
February 15, 2017,
Times Colonist
Smoking May Increase Risk of Death in Patients With CML
February 14, 2017,
Cancer Therapy Advisor
Firefighters ask lawmakers to expand their health care coverage
February 12, 2017,
New CML Data Post Signs on Route to Treatment-Free Remission
February 10, 2017,
Hybrigenics gives update on chronic myeloid leukemia study
February 10, 2017,
pharmaceutical daily news
Advancing Leukemia Treatments from the Heart of Paris
February 10, 2017,
Frontline Bosutinib Superior to Imatinib for Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase
February 9, 2017,
Neovia Starts Enrollment in Phase 1 Immunotherapy Trial for Advanced Cancers
February 9, 2017,
Immuno-Oncology News
Chronic Myeloid Leukemia: CD86 Expression Predicts Relapse
February 7, 2017,
Cancer Therapy Advisor
Allogeneic stem cell transplantation in chronic myeloid leukemia patients: Single center experience
February 6, 2017,
World Journal of Hematology
Leukemia drug holds promise to treat type 2 diabetes
February 4, 2017,
Knowridge Science Report
VIDEO: One Lowndes County Deputy Is Fighting More Than Just Crime
February 2, 2017,
Neovia Enrolls First Patient in Cancer Trial for Immunotherapy Enhancing Drug
February 1, 2017,
Yahoo Finance
Immune reconstitution and remission in CML
Book Review: Letters to Dr. Wiggy
January 31, 2017,
The Pace Chronicle
New step therapy law called step in right direction
January 31, 2017,
Old Cancer Drug Gets 1227% Price Hike in Frugal U.K.
January 30, 2017,
New study into leukemia offers clearer understanding of its biology
January 27, 2017,
Medical Xpress
Experience with Omacetaxine for TKI-Resistant TKI CML
January 26, 2017,
Seattle Biotech Neovia Begins Clinical Trial for Immunotherapy Enhancing Cancer Drug
January 25, 2017,
In CML, 'Half a Loaf' May Be as Good as None
January 25, 2017,
MedPage Today
Two Infants Treated with Universal Immune Cells Have Their Cancer Vanish
January 25, 2017,
MIT Technology Review
Single-cell epigenomic variability reveals functional cancer heterogeneity
January 24, 2017,
Genome Biology
Newcastle researchers welcome CML leukaemia trial success
January 24, 2017,
BBC News
Former Penn professor and 1952 Penn Medicine grad who revolutionized cancer research has died
January 23, 2017,
The Daily Pennsylvanian
Nilotinib for CML Associated With Improved Quality of Life
January 23, 2017,
Oncology Nurse Advisor
Adding Pioglitazone to Imatinib May Improve Response in CML
January 23, 2017,
Oncology Nurse Advisor
Alternative Mechanism for Treatment of Resistant CML
January 23, 2017,
CML stem cells: evasion for better invasion
Journal Blood
Ponatinib: Black Box Warning and Drug Interactions
January 17, 2017,
Cancer Therapy Advisor
10 Questions: David Chang, MD, PhD
January 14, 2017,
MedPage Today
Induction of p53 suppresses chronic myeloid leukemia
January 13, 2017,
Peter Nowell, who helped uncover first genetic sign of cancer, dies at 88
January 13, 2017,
Press Herald
Peter Nowell, who has died at 88, revolutionized cancer research — by accident
January 12, 2017,
Washington Post
Diagnosis and Upfront Therapy for CML
January 12, 2017,
TIDEL-II Trial for CML
January 12, 2017,
Using next-generation sequencing to identify biomarkers in CML
January 10, 2017,
VJHemOnc – Video Journal of Hematological Oncology
TKI Discontinuation and Chronic Myeloid Leukemia
January 10, 2017,
Cancer Therapy Advisor
Using ponatinib to treat highly resistant chronic myeloid leukemia, results from a Phase I trial
January 10, 2017,
Exploratory study on the impact of switching to nilotinib in 18 patients with chronic myeloid leukemia in chronic phase with suboptimal response to imatinib
January 8, 2017,
CD62L T-cell expression linked to TKI therapy response
January 6, 2017,
Cancer death rate now 25% lower than 25 years ago, report says
Janvier 6, 2017,
Chicago Tribune
Adding Pioglitazone Could Improve Molecular Response in CML Patients
Janvier 6, 2017
, Cancer Network
Cancer deaths fell 25 percent since 1991
Janvier 6, 2017,
Adding Pioglitazone to Imatinib May Improve Response Rate in CML
January 4, 2017,
Cancer Therapy Advisor
CML patients with deep molecular responses to TKI have restored immune effectors, decreased PD-1 and immune suppressors.
January 3, 2017,
Professor Peter C. Nowell, MD (1928-2016)
January 2, 2017,
Pathology and Laboratory Medicine
Female and Elderly Chronic Myeloid Leukemia Patients Often Do Not Receive an Adequate TKI Treatment
Blood 2016,
Journal Blood
Anti-Leukemic Effects of Venetoclax on Philadelphia Chromosome Positive Leukemia Cells
Journal Blood
100 Years of Chronic Myeloid Leukemia Prevalence in France
December 2016,
Journal Blood
Natural Killer Cells Play Role in Ability of CML Patients to Discontinue TKIs
December 29, 2016,
Cancer Network
Facing Cancer Diagnosis, Badass Young Woman Puts on Lipstick and Dances to "I'm a Survivor"
December 29, 2016,
Give Precision Medicine a Chance
December 28, 2016,
Woman shares devastating cancer diagnosis with her family by creating hilarious video to show disease won't define her
December 28, 2016,
Combination Chemotherapy Shows Promise in Patients with Blood Cancers
December 28, 2016,
Specialty Pharmacy Times
Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study
December 27, 2016,
Faster, Better, Safer—Getting CML Treatment Right
December 23, 2016,
PeerView Oncology
Enhanced targeting of CML stem and progenitor cells by inhibition of porcupine acyltransferase in combination with TKI.
December 23, 2016,
Family, community rally around Bessemer girl battling leukemia
December 16 2016,
New Castle News
Second Generation TKIs Can Be Safely Stopped in CML
December 13, 2016,
Cancer Therapy Advisor
Safety Data for TKI Cessation Emerges for Chronic Myeloid Leukemia
December 6, 2016,
Pfizer, Avillion's Bosulif comes out on top in first-line CML trial
December 6, 2016,
CML Patients Receiving TKI Can Successfully Discontinue Tx
December 5, 2016,
Medpage today
Cutting Dose, Instead of Stopping Therapy, in Patients With CML
December 5, 2016,
Leukemia Drug Bosulif Succeeds in Phase 3 Trial
December 5, 2016,
Managed Care magazine
CML-CP: Second TKI Discontinuation Safe and Successful
December 5, 2016,
Cancer Therapy Advisor
Halving the TKI dose safe, cost effective in CML patients with stable remissions
December 4, 2016,
At 2 Years, No CML Found in Half of Patients Who Stopped TKI Therapy
December 4, 2016,
Cancer Network
TKI Cessation Strategies Emerging for CML
December 4, 2016,
Meeting the New Challenges in CML Therapy
December 2, 2016,
iCMLf forum
Ponatinib Approved for CP-CML Not Indicated for Prior TKI
December 1, 2016
, Cancer Therapy Advisor
Fecal Occult Blood Test With Colonoscopy May Detect Colitis Risk Among CML Patients
November 30, 2016
, Cancer Therapy Advisor
TKI-induced Cardiovascular Toxicity in Chronic Myeloid Leukemia
November 29, 2016,
Cancer Therapy Advisor
FDA Fully Approves Iclusig for Chronic Myeloid Leukemia
November 29, 2016,
Rare Disease Report
Summer Project Turns Into Leukemia Testing Breakthrough
November 28, 2016,
New York Times
Pleural effusion linked to first-line dasatinib molecular response
November 28, 2016,
CML somatic mutation analysis linked to patient outcome
November 28, 2016,
Why Might Patients Skip Their Cancer Treatments, and How Can We Improve Compliance?
November 25, 2016,
Bosutinib Offers Long-Term Efficacy in CML Patients Who Failed TKI Therapy
November 23, 2016,
Cancer Network
Transforming cancer care in MENA region
November 23, 2016,
Kuwait Times
Money in Medicine: Brian Druker on why he gets money from Gilead, not Gleevec
November 22, 2016,
Portland Business Journal
Elle Halliwell's sheer terror over battling leukemia while pregnant
November 21, 2016,
Yahoo7 Be
A little card with a big task: Saving lives from CML
November 18. 2016,
Fred Hutch News Service
Over 75% of CDF drugs reappraised by NICE now approved for routine use
November 17, 2016,
The pharmletter
Roche, Bristol-Myers cut cancer drug prices to win UK approval
November 16, 2016,
CRISPR gene-editing tested in a person for the first time
November 15, 2016,
Darwinian Oncology Comes of Age: Evolutionary Biologists Offer Competing Theories of Cancer
November 14, 2016,
Cancer Therapy Advisor
The Mast Cell: New Target in SpA?
November 12, 2016,
Medpage Today
Bosutinib for CML After Progression With First-line TKI
November 10, 2016,
Cancer Therapy Advisor
CD62L Plasma Levels May Predict Response to TKIs in Early CML-CP
November 9, 2016,
Cancer Therapy Advisor
Immune Cell Protein Expression Could Offer Predictive Biomarker in CML
November 9, 2016,
Cancer Network
'One-fifth of cancer patients face work discrimination'
November 7, 2016,
BBC News
Caveolin-1 contributes to realgar nanoparticle therapy in human chronic myelogenous leukemia K562 cells
November 7, 2016,
Dove Medical Press
Generic imatinib for chronic myeloid leukaemia patients
November 4, 2016,
Blood and Lymphatic cancer – Leukemia Care
Geron Announces Presentations at American Society of Hematology Annual Meeting
November 3, 2016,
CML Patients With Prior Malignancies Have Excellent Outcomes
October 28, 2016,
Cancer Network
CML patient motivation for TFR remission attempts highlighted
October 28, 2016,
MATE1 protein crucial for imatinib uptake
October 27, 2016,
Model Suggests Best Option in CML Is Sequential Combination of Dasatinib and Nilotinib
October 25, 2016,
Cancer Therapy Advisor
History of Prior Malignancies Do Not Appear to Affect CML Outcomes
October 24, 2016,
Cancer Therapy Advisor
Why Cancer Patients Don't Take Their Medications
October 24, 2016,
Med School's Hard Enough. This Guy's Doing It With Cancer – about Joshua Novy
October 20, 2016,
Joshua Novy's Fundraiser: Cancer Patient helping other Cancer Patients
October 20, 2016,
Optimal treatment plan for chronic myeloid leukemia suggested by mathematical modeling
October 20, 2016,
Medical Xpress
Childhood CML Survival Worst for Children Under 5 Years Old
October 19, 2016,
Cancer Therapy Advisor
Long-term later-line bosutinib benefits CML patients
October 18, 2016,
Targeted Power: Improving Prognoses for Patients With Chronic Myeloid Leukemia
October 17, 2016,
Mutation Pattern Predicts Patients Likely To Fail TKI Therapy in CML
October 14, 2016,
Cancer Therapy Advisor
Bernie Sanders' Tweet Cost This Drug Company Millions
October 14, 2016,
Ariad raises price of its leukemia drug four times so far this year
October 13, 2016,
American Pharmacists Association
Disparities in Childhood CML Outcomes Persist Among Some European Countries and the US
October 11, 2016,
Cancer Therapy Advisor
Lack of Cost-sharing Subsidies Reduces TKI Initiation and Adherence in CML
October 11, 2016,
Cancer Therapy Advisor
Cancer in Retreat on One Front: Fewer Children Are Dying
October 10, 2016,
The New York Times
Herbal Drug Proves Effective Against AML
October 10, 2016,
Asian Scientist Magazine
Some Patients With Chronic Myelogenous Leukemia Delay Treatment Because of Cost
October 10, 2016,
Dr. Jerald P. Radich on Treatment Considerations with Generic Imatinib in CML
October 8, 2016,
CML Patients on Medicare Delaying TKIs Due to Cost
October 6, 2016,
Oncology Nursing News
Long-term Follow-up Confirms Safety of Imatinib Discontinuation in CML
October 5, 2016,
Cancer Therapy Advisor
Cancer patients holding off on use of lifesaving medicine
October 5, 2016,
News Chief
New drug delivery process gives hope to leukemia patients
October 3, 2016,
The Times of India
Dr. Jerald Radich on Impact of Generic Imatinib in CML
October 1, 2016,
Incorporating Generic Imatinib Into Frontline Treatment for CML
October 1, 2016,
Prolonged Imatinib Therapy Linked With Deeper Molecular Response in CML-CP
September 27, 2016,
Cancer Therapy Advisor
Combined Treatment May Lead to Cure for Chronic Myeloid Leukemia
September 26, 2016,
Cancer Therapy Advisor
Leukemia patients stand strong
September 25, 2016,
Daily Star
Imatinib Less Beneficial for Patients With CML in Accelerated Phase
September 23, 2016,
Cancer Therapy Advisor
Response Rate Similar Between Low- and Standard-dose Ponatinib
September 23, 2016,
Cancer Therapy Advisor
Compulsory License On Imatinib Mesylate – Drug Determined To Be Of Public Interest By The Colombian Government
September 21, 2016,
Mondaq News Alerts
Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
September 21, 2016 ,
Oncology Nurse Advisor
Citrus Valley football rallies behind Nelson Natividad in his battle with leukemia
September 20, 2016,
The Sun High School
EZH2 May Be Required for CML Initiation, Could Represent Therapeutic Target
September 19, 2016 ,
Cancer Network
Molecular monitoring in CML – getting to a safe place
September 17, 2016,
Precision medicine breakthrough for Chronic Myeloid Leukaemia
September 15, 2016,
University of Glasgow
Prospect of shorter treatment and cure for chronic myelogenous leukemia
September 14, 2016,
Havard Gazette
High school cheerleader with cancer is moved to tears of joy after ALL 57 players on the football team place a rose at her feet at the start of a game
September 14, 2016,
CML Patients Still Benefit from Transplant
September 13, 2016,
MedPage Today
Leukaemia drug gets the green light for NHS use
September 13, 2016,
Scottish Daily Record
Cancer Breakthrough: US Approves Leukemia Treatment
September 8, 2016,
Diseases Cure
Combination therapy shows promise for chronic myeloid leukemia
September 7, 2016,
Science Daily
Dr. Donnellan on TFR in Patients With CML Treated With Nilotinib
September 7, 2016,
Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells
September 7, 2016,
Science translational Medicine
EUTOS Registry Represents Benchmark for Evaluation of New CML Treatments
September 6, 2016,
This Type of Cancer is a Growing Concern in the Black Community
September 6, 2016,
The Milwaukee Community Journal
Chinese Cancer Patients Are Illicitly Importing and Preparing Their Own Drugs
September 1, 2016,
Blood cancer treatment linked to distinct increase in molecular age of immune cells
September 1, 2016,
News Medical
Higher EUTOS Risk Scores Linked With Delayed Response Rate in CML
August 31, 2016,
Cancer Therapy Advisor
Dragway is benevolent
August 31, 2016,
Clay Today Online
Living with blood cancer, leading a normal active life
August 30, 2016,
The Straits Times
EUTOS Registry Shows Good CML Outcomes Outside Trials
August 30, 2016,
Cancer network
I was diagnosed with Leukaemia & found out I was pregnant
August 30, 2016,
Chronic myeloid leukemia patients call for quality and consistency when generics are introduced to treat their cancer
August 26, 2016,
Elle Halliwell finds out she is pregnant days after diagnosed with a rare cancer
August 26, 2016,
Mail Online
Elle Halliwell reveals how she is coming to terms with having leukaemia and being pregnant with her first child
August 25, 2016,
The Daily Telegraph
Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity
August 25, 2016,
European Respiratory Journal
Be The Match and save a life
August 25, 2016,
NICE approves CDF drugs Alimta and Bosulif for routine NHS use
August 24, 2016,
The Pharma Letter
Pfizer gobbles up cancer drug maker in $14 billion deal
August 24, 2016,
World Socialist Web Site
Bacteria coaxed to deliver chemo drugs right inside tumours
ugust 17, 2016,
Leukemia patient survey shows that serious issue patients should know
August 17, 2016,
Daily Beast
These Ph.D. students are turning a cancer test into a business
August 16, 2016,
Technically Baltimore
Nilotinib, Dasatinib Offer Similar Outcomes in CML Patients
August 15, 2016,
Cancer Network
IBM's Watson Detected Rare Leukemia In Just 10 Minutes
August 15, 2016,
Asian Scientist Magazine
Dasatinib and Nilotinib Similarly Efficacious for CML in Chronic Phase
August 11, 2016,
Cancer Therapy Advisor
CML-CP: Dasatinib, Nilotinib Associated With Similar Survival Outcomes as Frontline Therapy
August 10, 2016,
Oncology Nurse Advisor
Rationale and motivating factors for treatment-free remission in chronic myeloid leukemia
August 10, 2016,
Leukemia & Lymphoma
Phases of Chronic Myeloid Leukemia
August 9, 2016,
ABCB1 Overexpression Predicts Poor Imatinib Response in CML Patients
August 9, 2016,
Clinical Oncology News
ABCB1 mRNA Could Predict TKI Response in CML
August 5, 2016,
Cancer Network
Young SOM Entrepreneurs Win National Contest
August 5, 2016,
UMB News
Cardiovascular events associated with use of TKIs in CML
August 5, 2016,
Pharmacy Today
Social Support Crucial for Patients With CML Receiving Lifelong Targeted Therapy
August 4, 2016,
Oncology Nurse Advisor
Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients
July 29, 2016,
Journal of Hematology & Oncology
Fremont helps stranded Connecticut man
July 29, 2016,
Fremont News Messenger
Early detection of leukemia patients' resistance to therapy
July 28, 2016,
Science Daily
TKI Duration and Molecular Response Pivotal for Survival With Chronic Myeloid Leukemia
July 28, 2016,
Cancer Therapy Advisor
Half of Patients in Remission 11 Months After Nilotinib Discontinuation
July 28, 2016,
Cancer Therapy Advisor
93 percent of advanced leukemia patients in remission after immunotherapy
April 27, 2016,
Breakthrough brings blood cancer cure closer
July 27, 2016,
The Advertiser
Adelaide researchers in world-first breakthrough for people living with chronic myeloid leukaemia
July 27, 2016, Herald Sun
Line-up for Saturday Night with Miriam revealed
July 22, 2016,
Patients with Chronic Phase CML Can Safely Conclude TKI Treatment
July 21, 2016,
Targeted Oncology
Veteran fights largest battle yet – cancer
July 14, 2016,
Nassau County Record
Novartis cancer drug to be tested for Parkinson's disease
July 13, 2016,
Dubai-based Biologix FZCo. to distribute leukemia drug in the Middle East
July 13, 2016,
Gulf News Journal
TKI-treated Patients With CML May Have Increased Risk of Vascular Events
July 13, 2016
Cancer Therapy Advisor
Ipilimumab Shows Impressive Activity After HSCT Failure
July 13, 2016,
Eastleigh Football Club raising funds for charity that saved manager Chris Todd's life
July 8, 2016,
Southern Daily Echo
Oral chemo bill could save lives in Pa. — better late than never
July 6, 2016,
The Morning Call
Roz Purcell: 'We were advised to get a dog when my sister was diagnosed with cancer'
July 4, 2016,
Irish Independent
Green Tea Helps Prevent And Treat Leukemia
July 4, 2016,
Huffington Post Canada
Efficacy and safety of second-line ponatinib after failure of a single previous tyrosine kinase inhibitor for chronic myeloid leukemia patients in chronic phase
June 2016,
Leukaemia drug shows promise in ovarian cancer (dasatinib)
June 30, 2016,
Post-Transplant TKI Maintenance Yields Promising Results in High-Risk CML, ALL
June 29, 2016,
Cancer Network
Life Span of CML Patients Approaches Usual Limits
June 28,2016,
Life Expectancy in CML Patients Approaching General Population's
June 24,2016,
Cancer Network
Brexit big blow to UK science, say top British scientists
June 24, 2016,
Brexit could lead to longer waiting times for new medicines, warn experts
June 23, 2016,
New Findings on Chronic Myeloid Leukaemia, Possible Therapeutic Approaches
June 22,2016,
Potential therapeutic approaches to combat chronic myeloid leukemia
June 21, 2016,
CML No Longer Spells Early Death
June 20, 2016,
MedPage Today
Babe Ruth's granddaughter helps with local foundation
June 20, 2016,
Choosing the most effective cure for chronic myeloid leukemia
June 17, 2016,
Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia
June 17, 2016,
Stopping TKI Treatment Is Safe for Patients With Chronic Myeloid Leukemia
June 16, 2016,
ARIAD Launches CMLRisks.com To Expand Awareness Of Chronic Myeloid Leukemia Resistance And Intolerance
June 16, 2016,
Incidence of lymphocytosis linked to higher dasatinib response rate in CML
June 14, 2016,
CML Remissions Continue Even After TKI Drugs Are Stopped
June 13, 2016,
Small-molecule tool could reduce leukemia cell regeneration
June 10, 2016,
MedCity News
Stopping TKIs Proven Safe in Chronic Phase CML
June 10, 2016,
UC regents appoint Dr. Owen Witte University Professor
June 10, 2016,
UCLA Newsroom
NICE Not Alone in Pushback on Cancer Drug Prices
June 10, 2016,
AJMC.com Managed Markets Network
CML Patients Treated With TKIs May Have Increased Risk of Second Malignancies
June 10, 2016,
Cancer Therapy Advisor
ARIAD Launches CMLRisks.com To Expand Awareness Of Chronic Myeloid Leukemia Resistance And Intolerance
June 10, 2016,
Clinical Leader
Chronic Myelogenic Leukemia Management in the TKI Era: Patient Compliance is Still Critical
June 9, 2016,
Cancer Therapy Advisor
Scientists identify drugs to target 'Achilles heel' of Chronic Myeloid Leukaemia cells
June 8, 2016,
The University of Manchester
Cancer Breakthrough: Scientists find drugs to target 'Achilles heel' of leukaemia
Jun 8, 2016,
Cancer patients with ACA policies swiftly reach out-of-pocket caps
June 7, 2016 ,
Medical Xpress
Over 50% of eligible Ph+ CML patients maintain TFR after stopping Tasigna
June 5, 2016 ,
The Pharma Letter
Who Runs Washington? The Long Reach of Big-Pharma
June 4, 2016,
Center for Research on Globalization
Nilotinib induces treatment-free remission in patients with chronic phase CML
June 4, 2016,
New hope for chronic myelogenous leukemia patients: dasatinib offers better efficacy with shorter treatment
June 3, 2016,
The concept of treatment-free remission in chronic myeloid leukemia
June 3, 2016,
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia
June 3, 2016,
Novartis data show more than 50 percent of eligible Ph+ CML patients maintain Treatment-free Remission (TFR) after stopping Tasigna®
June 3, 2016,
My Husband's Rare Cancer
June 2, 2016,
PLoS Blogs
Neither Trump nor Clinton a true leader
June 2, 2016,
Kennebec Journal & Morning Sentinel
Scientists reveal breakthrough skin cancer drug
May 31, 2016,
BABW News
Cancer survivor cycling to Paris for Bloodwise after Leukaemia diagnosis
May 28, 2016,
Essex Chronicle
It's Blood Cancer Day, how is Biotech fixing it?
May 27, 2016,
11 Common Immune System Diseases and What They Do to You
May 26, 2016,
Personalized Treatment for CML Through DNA Digital Assay
May 26, 2016,
LWW Journals
NBA Legend's Message to Patients and Survivors of Cancer: Listen to Your Doctors
May 25, 2016,
First-line Dasatinib Safe, Effective for Long-term Treatment of CML-CP
May 25, 2016,
Cancer Therapy Advisor
DelMar Pharmaceuticals Announces Successful Completion of End-of-Phase 2 Meeting with FDA on VAL-083 for the Treatment of Refractory Glioblastoma Multiforme
May 25, 2016,
Benzene suit filed against Texaco, 36 other companies for toxic emissions
May 24, 2016,
Southeast Texas Record
Sunday Special: Jackson's Pritt sets sights on Olympic trials
May 23, 2016,
Canton Repository
Count-down to ASCO underway
May 23, 2016,
The Pharma Letter
Generics help force drug prices lower
May 23, 2016,
Sun Sentinel
Five-Year Results Support First-Line Dasatinib Use in CML
May 23, 2016,
Cancer Network
Friends, relatives support cancer victims at Relay for Life
May 21, 2016,
The Daily Item
BCR-ABL tyrosine kinase inhibitors: risk of hepatitis B reactivation
May 19, 2016,
30 years after cancer treatment, Encinitas man still rocking
May 19, 2016,
Encinitas Advocate
ARIAD Announces Pricing and Reimbursement for Iclusig in France
May 19, 2016,
Business Wire
Brexit would threaten world-class British research, major report warns
May 18, 2016,
Allogeneic HSCT offers good survival for select TKI-refractory CML patients
May 18, 2016,
News Medical
CML treatment-free remission criteria outlined
May 18, 2016,
How Colombia's Drugs Battle With Novartis Could Change Healthcare in Latin America
May 18, 2016,
Americas Quaterly
Global Leukemia Therapeutic Market (2015 – 2021) : PMR
May 16, 2016,
Health activist and surgeon Dr Gopal Dabade fights against corrupt medical practices
May 15, 2016,
Leaks Show Senate Aide Threatened Colombia Over Cheap Cancer Drug
May 14, 2016,
The Intercept
Early recognition of intraventricular hemorrhage in the setting of thrombocytosis in the emergency department
May 12, 2016,
Dove Medical Press
Cancer survivor graduates from UT Dallas
May 12, 2016,
'Life-saver' to be honored by Areyvut
May 11, 2016,
New Jersey Jewish News
Cancer Drug Linked to Case of Scurvy
May 11, 2016,
Monthly Prescribing Reference
Q&A With Dr. Elias Jabbour, MD, Highlights Evolving Treatment Landscape for CML, Pricing Barriers
May 11, 2016,
Cancer Therapy Advisor
13 Things To Remember If You Love Someone With Leukemia
May 10, 2016,
Diseases Cure
Barkle's sparkle in £5k charity challenge- inspired by brave Abi, 3, who is battling leukaemia
May 7, 2016,
Prior Malignancies, Autoimmune Disorders Increased in CML Patients
May 5, 2016,
Cancer Network
Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation
May 5, 2016,
Onco target
Multitargeted Therapies Promiscuous Drugs and Combination Therapies Market: Historical, Current and Projected industry size and Recent Industry Trends
May 5, 2016,
Mumbai Diary: Thursday Dossier
May 5, 2016,
Leukemia survivor deals with aftermath while in remission
May 5, 2016,
2 Sizzling Hot Biotechnology Stocks: Immunomedics Inc. (IMMU), CTI BioPharma Corp. (CTIC)
May 4, 2016,
Yissum and BioTheryX Sign Licensing Agreement for the Development of Next-Generation Protein Degradation and Immunomodulatory Treatment for Hematological Cancers
May 4, 2016,
PR Newswire
Colombia reportedly set to override Novartis patent on a key cancer drugColombia reportedly set to override Novartis patent on a key cancer drug
May 3, 2016,
PegIFN Improves Responses to Dasatinib in Newly Diagnosed CML Patients
May 3, 2016,
Cancer Network
Argus-Courier wins four awards in CNPA Better Newspapers Contest
May 2, 2016,
Argus Courier
Soon, centre to facilitate bone marrow transplantation in Indore
May 1, 2016,
Hindustan Times
A DNA Sequencer in Every Pocket
April 29, 2016,
The Atlantic
Firefighters who donated bone marrow say it's an 'honor' to meet recipients whose lives they saved
April 29, 2016,
New York Daily News
Art Therapy for Leukemia and Other Cancers
April 27, 2016,
Sinthia Cousineau
Promising Secondary Endpoints for Ponatinib in CML Despite Early EPIC Trial Termination
April 26, 2016,
Cancer Therapy Advisor
Pacritinib's Potential to Eradicate Therapy-Resistant Leukemia Stem Cells
April 25, 2016,
LWW Journals
Researchers Identify Risk Factors for Bosutinib-related Cardiac, Vascular Toxicities
April 25, 2016,
Cancer Therapy Advisor
Chronic inflammation leads to imbalanced blood system and potentially cancer risk
April 25, 2016,
How Ontario's stem-cell transplant waiting list failed a dying teen
Apr 23 2016,
Toronto Metro
Vascular Events Remain Problem for Ponatinib in CML
Apr 22, 2016,
Cancer Network
Bosutinib shows 'low' vascular, cardiac event risk profile
April 21, 2016,
Targeted therapy: Generic imatinib — impact on frontline and salvage therapy for CML
Apr 21, 2016,
Tailoring immune cells to target leukemia
April 21, 2016,
Fred Hutch
Bosutinib shows 'low' vascular, cardiac event risk profile
April 21, 2016,
BCR-ABL halving time indicates CML prognosis during front-line TKI BCR-ABL halving time indicates CML prognosis during front-line TKI
April 21, 2016,
Did I Miss Something?
April 21, 2016,
Patient Power
Alpha-2, 3-sialyltransferases regulate the multidrug resistance of chronic myeloid leukemia through miR-4701-5p targeting ST3GAL1
April 18, 2016,
Cancer group coalition wins right to contest in Philippines poll
April 17, 2016 ,
Gulf News
Williams benefit Saturday at KCs
April 15, 2016,
Jamestown Sun
CML molecular monitoring: Practical advice
April 15, 2016,
Rapid BCR-ABL Reduction Is Predictive of Response in CML
April 15, 2016,
Cancer Network
The impact of multiple low-level BCR-ABL1 mutations on response to ponatinib
April 14, 2016,
Study compares ponatinib, imatinib for newly diagnosed chronic myeloid leukemia
April 14, 2016,
Pharmacy Today
Efficacy of First-line Ponatinib in CP-CML Remains Unclear
April 14, 2016,
Oncology Nurse Advisor
Ponatinib Currently Not Indicated As First Line CML Chronic Phase Therapy
April 13, 2016,
Why can't Illinois patients grow their own weed?
April 13, 2016,
Chicago Reader
Dickinson holds fourth annual bone marrow registry drive
April 13, 2016, The Sentinel
Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial
April 12, 2016,
Cost-sharing Creates Barrier to Treating Life-threatening Illness
April 12, 2016,
Oncology Nurse Advisor
Closing Thoughts on Managing Chronic Myeloid Leukemia
April 11, 2016, OncLive
A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML
April 8, 2016,
Blood Cancer Journal
A career in cancer research? Computational skills wanted
April 8, 2016,
Science Mag
Value in health care: Time to stop scratching the surface
April 7, 2016,
American Entreprise Institute
Generic imatinib cost-effective first-line treatment for CML
April 7, 2016,
Relay for Life set for April 15 in Tifton
April 6, 2016,
Tifton Gazette
Medicare's catastrophic drug insurance can be a catastrophe for consumers
April 6, 2016,
PBS NewsHour
Advice for Patients With CML Traveling While On Oral Chemotherapy
April 4, 2016,
RAAF jet fuel: Submarine veterans call for recognition of 'link' between fuel and blood cancers
April 4, 2016,
Meet real Michiganders affected by state spending
April 4, 2016,
Lansing State Journal
Case Study: Selecting a Tyrosine Kinase Inhibitor in CML
April 1, 2016,
Stamp appeal grows in fight against cancer
April 1, 2016,
Burton Mail
New Analysis Suggests 2013 ELN Categories Reliably
Predict CML Patient Long-term Outcomes
March 31, 2016,
Cancer Therapy Advisor
Newer Generation TKIs May Be More Effective Than Imatinib for CP-CML
March 30, 2016 ,
Cancer Therapy Advisor
Oh, New Mutation? Now, We'll Try This Treatment
March 29, 2016,
India's largest drug maker approved by US FDA Approval for Famous Anti Cancer – Corona Health
March 29, 2016,
Daily Star Gazette
Scientists Find Accidental Cure for Type 2 Diabetes: Imatinib
March 29, 2016,
AJMC.com Managed Markets Network
Dasatinib Commonly Induces Lymphocytosis in CML Patients
March 29, 2016,
Increased Serum Creatinine Reversible Upon Imatinib Discontinuation
March 28, 2016,
Cancer Therapy Advisor
Cancer Treatment's New Direction
March 28, 2016,
Wall Street Journal
Ulsan National Institute of Science and Technology(UNIST)
March 27, 2016,
Dr. Brian Druker: "Anatomy of a Breakthrough in Targeted Cancer Treatments" | Talks at Google
March 25, 2016
Talks at Google
Patients With Additional Chromosomal Abnormalities in Chronic CML Have Worse Prognosis, Survival
March 23, 2016,
Cancer Therapy Advisor
Delays in availability of affordable generic drugs exacerbate high cancer drug prices in the United States
March 23, 2016,
EU High Court Upholds Orphan Exclusivity Ruling
March 23, 2016,
Regulatory Focus
Stem Cell Transplant in Chronic Myeloid Leukemia
March 22, 2016,
Moving treatment-free remission into mainstream clinical practice in CML
March 22, 2016,
Journal Blood
TGF-alpha, IL-6 Levels Predict Responses and Outcomes in CML
March 22, 2016,
Cancer Network
Generic Drug Could Slash Treatment Costs for Cancer Patients
March 21, 2016,
The presence of C/EBPα and its degradation are both required for TRIB2-mediated leukaemia
March 21, 2016,
Frontline Nilotinib Best Choice for Treatment of Patients With CML-CP
March 18, 2016,
Cancer Therapy Advisor
Cancer Therapy Advisor
Kareem Abdul-Jabbar Discusses Living With CML
March 18, 2016,
Real-life data show feasibility of imatinib discontinuation in CML
March 17, 2016
Non-Hodgkin Lymphoma Elevated in Imatinib-Treated CML Survivors
March 16, 2016,
Cancer Network
Generic Gleevec Will Hurt Novartis -- But Save Millions In Health Costs
March 16, 2016,
Switching Therapy in Chronic Myeloid Leukemia
March 15, 2016,
Using generic cancer drug could save many millions of dollars
March 15, 2016,
Medical Xpress
DelMar's lead product candidate bags second Orphan Drug tag
March 15, 2016,
Seeking Alpha
PTEN opposes negative selection and enables oncogenic transformation of pre-B cells
March 14, 2016.
Drug defies cancer and market logic
March 13, 2016,
Concord Monitor
If you're 30+, you should know about this blood cancer
March 13, 2016,
Bucket list dreams come true for North Walsham schoolgirl with rare form of blood cancer
March 12, 2016,
Eastern Daily Press
Once Patent Protection Is Lost, Imatinib as Initial Treatment for CP-CML Will Be Most Cost-effective Strategy
March 11, 2016,
Cancer Therapy Advisor
Dasatinib, Nilotinib Safe and Effective in CML Patients With Renal, Liver Dysfunction
March 11, 2016,
Cancer Network
Imatinib in 2016: What will the era of generic targeted therapy for cancer look like?
March 10, 2016,
Leukemia claims Dartmouth Moosehead Dry pitcher at age
March 10, 2016,
Cape Breton Post
This drug is defying a rare form of leukemia — and it keeps getting pricier
March 9, 2016,
Washington Post
FDA Is Not the Problem
March 9, 2016,
Center For American Progress
Could CypA facilitate cancer progression through the Abl-Crk signalling pathway?
March 9, 2016,
Managing Toxicities from CML Treatment
March 8, 2016,
Estimating deep molecular responses in chronic myelogenous leukemia: a Bayesian approach
March 8, 2016,
CML: How Previous TKIs Affect Outcomes with Ponatinib
March 8, 2016,
LWW Journals
Cost of foreign cancer drugs to be halved in Chinese public insurance pilot scheme
March 8, 2016,
South China Morning Post
Older Patients With CML at Higher Risk for Mortality, Vascular Events
March 8, 2016,
Cancer Therapy Advisor
Stopping Imatinib Safe for CML Pts With Deep Response
March 5, 2016,
Clinical Oncology News
CML-CP Patients With Mild to Moderate Renal, Liver Dysfunction Can Safely Receive Frontline TKIs
March 4, 2016,
Cancer Therapy Advisor
As "Me-Too" Options Expand, Cost, Side Effects Become Considerations, McCullough Explains
March 4, 2016,
Couple looks to wedding after cancer diagnosis
February 29, 2016,
Northern Star
Family, friends run for local man living with leukemia
February 28, 2016,
Oakland Press
Update on the management of Philadelphia chromosome positive chronic myelogenous leukemia: role of nilotinib
February 28, 2016,
Dove Medical Press
Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV
February 26, 2016,
At AGBT, Researchers Describe Using Long Reads for Clinical Applications
February 26, 2016,
Researchers, Clinicians, Policy and Drug Development Experts, and Cancer Survivors Convene to Discuss Latest Advances and Challenges in Treating Blood Cancers
February 25, 2016,
Isabel Cunningham Holds CML Question-and-Answer Session With Jane Apperley, MD
February 24, 2016,
Cancer Therapy Advisor
Switching to Nilotinib May Reduce Imatinib-related Adverse Events in CML
February 23, 2016 ,
Cancer Therapy Advisor
Antibody-TKI Combination Impairs Leukemia Stem Cells
February 23, 2016, LWW Journals
CLINE: Mill Creek student has built a solid Foundation
February 23, 2016,
Gwinnett Daily post
He overcame cancer, now fights for others
February 23, 2016 ,
Asbury Park Press
EnvoyHealth Selected by Sun Pharma to Support Imatinib Mesylate Patient Program
February 22, 2016,
Citing higher cancer risk, lawmakers consider workers' comp provision for firefighters
February 22, 2016,
Meriden Record-Journal
Chronic Myeloid Leukemia Treatment Discontinuation
February 22, 2016,
Oncology nursing News
Mtss1 'tumour suppressor' for CMLMtss1 'tumour suppressor' for CML
February 17, 2016,
News Medical
BCR-ABL Tyrosine Kinase Inhibitors May Increase Cardiovascular Events in Chronic Myeloid Leukemia
February 16, 2016,
Cancer Therapy Advisor
Excitement at new cancer treatment
February 16,2016,
Birmingham to lead the way with breakthrough cancer treatment
February 16, 2016,
"Revolutionary" Cancer Therapy Yields Extraordinary Results In Human Trials
February 16, 2016,
Cell marker found for leukemia-initiating capacity in chronic myelogenous leukemia
February 15, 2016,
UAB News
The Write Stuff | Learning Kintsugi
February 11, 2016,
The Courier-Journal
At 5 Years, Nilotinib Offers Benefit Over Imatinib in CML
February 10, 2016,
Cancer Network
In CML: Radotinib as Frontline Therapy; Ponatinib Promising for T315I Patients
February 10, 2016,
Oncology Times
Importance of Monitoring Patients with Chronic Myeloid Leukemia
February 10, 2016,
Relief in sight for cancer patients
February 9, 2016,
Jackson Sun
Depression: cancer's invisible side effect
February 8, 2016,
New personalized DNA-based digital assay has potential to dramatically impact CML management
February 8, 2016,
February 8, 2016 News-Medical.net
Omacetaxine Mepesuccinate for Chronic Myeloid Leukemia
February 6, 2016,
Expert Review of Hematology
Edible Pedal founder battles Leukemia with support from restaurant community
February 5, 2016,
Sacramento Bee
New assay detects persistent disease in leukemia patients thought to be in remission
February 5, 2016 ,
Dr. Nguyen on ABL001 in Patients With CML
February 5, 2016,
Dasatinib, Nilotinib, Ponatinib Increase Vascular Occlusive Events
February 4, 2016,
Oncology Nurse Advisor
Measuring Response in Chronic Myeloid Leukemia Treatment
February 4, 2016,
Woman honoured for her work with leukaemia patients
February 2, 2016,
CML: Study Evaluates Long-term Outcomes After Imatinib Discontinuation
February 1, 2016
, Cancer Therapy Advisor
Upfront Treatment of Chronic Myeloid Leukemia CML
February 1, 2016,
Modest Price Cut Expected For Generic Version Of Cancer Pill Gleevec
February 1, 2016,
Sun Pharma launches Gleevec's generic in US
February 1, 2016,
Business Standard
What Is the Optimal Dose and Schedule for Dasatinib in Chronic Myeloid Leukemia: Two Case Reports and Review of the Literature
February 2016,
Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring
February 2016,
MTSS1 Protein May Act As Tumor Suppressor, Downregulated in CML
January 29, 2016,
Hematopoietic Transplant Remains Valid Option for CML in Era of TKIs
January 29, 2016,
Cancer Therapy Advisor
Elevated Imatinib Dose, Second-generation TKIs Have Superior Responses in CML
January 28, 2015,
Cancer Therapy Advisor
Select patients with CML may safely discontinue dasatinib
January 28, 2016,
Researcher Identifies Role of SETBP1 in Myeloid Leukemia Development
January 27, 2016,
India West
Insurance Status Determines OS in Patients With CML
January 27, 2016,
AJMC.com Managed Markets Network
Organic salons reject toxic beauty products
January 27, 2016,
Mountain Xpress
Novel oral transforming growth factor-β signaling inhibitor EW-7197 eradicates CML-initiating cells
January 26, 2016,
Cancer Science
Clinical Goals of Treating CML
January 24, 2016,
How A Canadian Researcher Is Advancing Breakthrough Therapies
January 22, 2016,
Personal Health News
Positive bosutinib response for elderly blast phase CML patient
January 22, 2016,
'Somewhere between a bomb and a shotgun,' precision medicine steps in
January 21, 2016,
Multiple Low-level BCR-ABL1 Mutations Not Associated With Poor Response to Ponatinib in CML
January 19, 2016,
Cancer Therapy Advisor
Costs of targeted anticancer drugs growing faster than usage
January 17, 2016,
CML: First-line Therapy with Dasatinib + Pegylated Interferon Induces Deep Molecular Responses
January 15, 2016
, LWW Journals
Radotinib Effective, Safe for Newly Diagnosed CML-CP
January 14, 2016,
Cancer Therapy Advisor
Novel Therapies Likely to Change Role of Stem Cell Transplants in Blood Cancers
January 14, 2016,
Early Personalization of Imatinib Dose May Improve Outcomes for CP-CML
January 14, 2016,
Cancer Therapy Advisor
Mutation Analysis in Chronic Myeloid Leukemia
January 14, 2016,
Insulin Sensitivity Improved With PPARy Antagonist Imatinib
January 13, 2016,
Pioglitazone, Other TZDs May Add Benefit to TKI Therapy in CML
January 11, 2015,
Ponatinib vs Allogeneic SCT Promising for T315I Mutation-positive CP-CML
January 11, 2016,
PPARγ ligands increase antileukemic activity of second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia cells
January 8, 2016,
Blood Cancer journal
BCR-ABL Transcript Type Predicts TKI Response in CML
January 6, 2016,
Cancer Therapy Advisor
See Archives before 2016
- Voir
avis de non-responsabilité
Vea nuestro
aviso legal
Copyright © 2010-2020 CMLeukemia.com


text:
Forgive the self-promotion, but I'll be speaking and participating in a roundtable at Crain's BtoB's NetMarketing Breakfast in Chicago this Thursday, October 6th. I've been strugling between two presentations, one regarding a significant study that breaks apart and measures each vehicle of marketing campaigns -- television, print, Internet, search engine marketing, radio spots, etc.; the other presentation is a view into a best practice Fortune 100 enterprise search engine optimization program. If you have a preference, please post it here. In either case, it's going to be a short presentation followed by an internet marketing roundtable with marketers from SBC, Accenture and 1Sync.
Use the promotional code PEDL when registering at BtoB's site and you'll save $10, making the final cost only $35. If you come, please stop by after the event and say hello.
Here's some of the details of the event:
At BtoB's NetMarketing Breakfast in Chicago on October 6th, you can...
*Network with your peers over a continental breakfast
*Learn from marketing experts as they present best practices in e-mail, e-commerce, online advertising, search marketing, webcasts and more
*Ask the questions you want answered during the Q&A
*Find helpful resources by visiting our sponsors' tabletop displays
BtoB's editor, Ellis Booker, will moderate the following panel:
* Peter DeLegge
* Christian Barnard, Executive Director, SBC Online
* Molly Spatara, Internet Marketing, Accenture
* Amy Fanale, Director of Global Marketing, 1Sync
Type the promotional code "PEDL" (without the quotes) when registering at: https://www.btobonline.com/calendarRegistration.cms?eventId=53 and you'll save $10.
Marketing Today Blog, written by Fortune 500 marketer, Peter DeLegge, addresses business-to-business (b2b) and business-to-consumer (b2c) marketing strategy, issues and trends giving special attention to digital and integrated marketing issues.
Sunday, October 02, 2005
Speaking at BtoB's NetMarketing Breakfast Thursday in Chicago - Oct 6 - Here's $10 Off
Posted by Marketing Today at Sunday, October 02, 2005
2 comments:
- Anonymous said...
Hello Peter,
I noticed an ad with your picture in BtoB that indicated you're with Motorola. Is that as an employee or a consultant? Are you still consulting? Unfortunately, I can't make the event, but I'd be interested in the presentations. Can you provide a link to your presentation here?
- Sun Oct 02, 02:31:00 PM CDT
- Anonymous said...
Can you tell me more about that studY that breaks apart and measures each vehicle of marketing campaigns??
- Mon Sep 25, 03:09:00 PM CDT
Subscribe to: Post Comments (Atom)

subset: commoncrawl


text:
Chinese students from Michigan State University, Central Michigan University and Michigan Technical University came in chartered buses to join the protest. Cars drove past honking and waving Chinese flags in support.
Diane Brown, public-safety spokeswoman for the university, said the crowd of demonstrators was estimated at about 600 to 700 people. Many wore T-shirts that read "Support Beijing 2008," a reference to the upcoming summer Olympics.
"We overseas Chinese students were infuriated by the violence in Tibet on March 14 and the interruption on the Olympic torch relay wire-pulled by the Dalai clique, so we decided to stage this protest to make our voice heard," said Chen Jinhui, a student at the University of Michigan and one of the organizers.
On their placards the protesters displayed pictures, diagrams and historical records, which were collected from the Internet, foreign media reports and books written by Chinese and Western scholars, on the facts of Tibet's history and development, as well as the Chinese view of what has been going on in Tibet since this March 14, and information concerning protests against the Olympic Torch relay.
Protesters also spoke with passerbys and local media about China's policy on Tibet and its contributions to the improvement of the living standard of the Tibetan people.
The protest led to heated verbal exchanges between pro-Chinese and pro-Tibetan demonstrators. They traded shouts of "One China" with "Open the door! Let's see what's happening inside Tibet."
The exiled Tibetan spiritual leader spoke before more than 7,000 at the school.
American Chinese and Chinese students across the United States have been staging peaceful protests against the Dalai Lama's "separatist activities" as he tours the the United States.
In Rochester, Minnesota, several hundred Chinese protesters turned out.
Hundreds more were on hand during the Dalai Lama's stop in Seattle earlier.
"Wherever Dalai goes, he will always meet protests from Chinese people and all peace-loving folks," Ge Yan, a Chinese student studying in Minnesota, told Xinhua on Friday.
Meanwhile, AFP reports several thousand Chinese also rallied Saturday in Paris, Britain, Berlin and Los Angeles in support of their country and against allegedly biased media coverage of the Olympic torch relay and unrest in Tibet.
In Paris Saturday, up to 4,000 Chinese students and other expatriates gathered in the Place de la Republique wearing T-shirts daubed with the slogan "One China, One family" and brandishing signs critical of the western media, police said.
More than 1,000 people, mainly students, also gathered outside the BBC's offices in Manchester, north-west England, while around 300 staged a demonstration outside the Houses of Parliament in London.
Several hundred pro-Chinese activists also demonstrated in Berlin's Potsdamer Platz in the business district gripping banners with messages like "Media = untruths," and "China Olympia, one world, one dream."
In Los Angeles, police said up to 5,000 people gathered outside the Hollywood offices of broadcaster CNN in protest against one of the channel's commentators, Jack Cafferty, who described China as a "bunch of goons and thugs."
The channel has since apologized and said the April 9 remarks referred "only" to the Chinese government, not the people, but the row only added to the anger felt by many Chinese worldwide following protests during the Olympic torch relay.
In China itself fresh protests broke out on Sunday in reaction to the Western media's coverage of China's handling of Tibet.
The latest demonstrations came after thousands of Chinese rallied Saturday in support of their country, with branches of the French retailer Carrefour targeted.
People gathered in front of Carrefour stores across the country, chanting slogans of "Oppose Tibet independence" and "Oppose CNN's anti-China statements," the official Xinhua news agency said.
For example, more than 1,000 people assembled in front of a Carrefour store in the northwestern city of Xian holding protest banners.
Media coverage of the demonstrations in China show the majority of the people who participated are Chinese youths below the age of 30.
The blog Awakening China says:
"...on the many Chinese forums and bulletins across China used by most educated young netizens, in which the Western governments and its people were unable to understand the extent of it because of the language barrier, were filled with anti-Western sentiments, some bordering on deep anger and hatred which may take one or two generations to nullify these negative effects."
The following is from CCTV International (China).
Overseas Chinese hold demonstrations to support Beijing Olympics
Overseas Chinese held peaceful demonstrations on Saturday in the US, France, Britain and Germany over distorted reports about China in western media. Their rallies were also aimed at showing support for the Beijing Olympics.
Sweltering weather didn't dampen their enthusiasm at the rally on Capitol Hill in Washington DC. Participants say inaccurate coverage by some western media about events in Tibet has triggered anger among overseas Chinese.
Even some Americans are expressing concern over the reports.
Lawyer Robert Fabrikant said, "I've been to the Tibet region and certainly the Chinese government has done a lot for the Tibet people. And I think many Americans are worried that they can't get the true stories from their own media here."
In London, demonstrators covered their mouths with masks in a silent protest against the reporting on Tibet in the British media. To help clear up misinformation, photographs taken during the Tibet riots were shown beside pictures with distorted information that some western media presented to the world.
In France, incensed by disruptions of the Olympic torch relay in Paris, and an attack on disabled Chinese torchbearer Jin Jing, demonstrators sang and cheered for the Beijing Olympics.
In Germany, about 3,000 Chinese students gathered in Berlin to protest biased news coverage by some German media and to support Beijing Olympics.
An overseas Chinese said, "Most Chinese trust Germans. But I also think most Germans are not very familiar with a lot of information, particularly about the history of Tibet."
Those who took part in the protests say they hope their actions help local media and local people better understand China and the Beijing Olympics.


text:
Here I am Lord. You called me.
Discernment Retreats
These are silent retreats that include adoration and opportunities for confession, talks on vocational discernment and the Regnum Christi spirituality, and a chance to speak personally with the Vocation Director.
Atlanta, GA:
- March 9-11, 2018
- May 21-25, 2018
Come and See
This course allows you to spend a longer time living in one of our communities so as to get a more profound experience of what everyday life is like for the consecrated women. You will share in our community life, prayer and apostolate. It includes conferences, adoration and personal accompaniment by the Vocation Director.
- June 1-15, 2018 in Atlanta, GA
For more information contact Adrienne Rolwes at: arolwes@re


text:
I Found An Old, Old, Outlook Form in my new Outlook!
So I've never come across this before:
Now, the fact that I've never seen it before is not the fact that caught my attention, it's that the form clearly hasn't seen the light of day for some time. If you look at the UI/UX design, it seems to be a carry over from a time gone by.
So why is this interesting? Because if you think about it, somewhere buried deep inside all our apps are areas of code that have not been seen for some time. It's a form buried in a DLL called in this example, perhaps, "ShowConflictMessage()", where a unit test case has not been written for or has been but dropped off the main test line, and therefore, has never been seen by the most recent ship team.
Functionally it still works, but from a completeness point of view, it's not consistent with the rest of the application.
And because the use case is so obscure, customers who see it either don't make the connection that it's not inline with the rest of the product, or don't care enough to tell anyone, so zero feedback = zero change.
I wonder how many developers out there, have weird and wonderful little skeletons buried deep in their DLLs? I suppose that's a good +1 for a high percentage test case coverage.
Technorati Tags: Random